RXDX
Goldman Sachs’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-204,858
| Closed | -$22M | – | 5251 |
|
|
2023
Q1 | $22M | Sell |
204,858
-164,266
| -45% | -$17.6M | 0.01% | 1463 |
|
|
2022
Q4 | $40.6M | Buy |
369,124
+127,134
| +53% | +$14M | 0.01% | 1107 |
|
|
2022
Q3 | $14.3M | Buy |
241,990
+29,552
| +14% | +$1.74M | ﹤0.01% | 1855 |
|
|
2022
Q2 | $6M | Sell |
212,438
-85,290
| -29% | -$2.41M | ﹤0.01% | 2525 |
|
|
2022
Q1 | $11.2M | Buy |
297,728
+259,436
| +678% | +$9.8M | ﹤0.01% | 2144 |
|
|
2021
Q4 | $1.51M | Sell |
38,292
-131,442
| -77% | -$5.2M | ﹤0.01% | 3702 |
|
|
2021
Q3 | $4.02M | Buy |
+169,734
| New | +$4.02M | ﹤0.01% | 2936 |
|
|
2021
Q2 | – | Sell |
-59,083
| Closed | -$1.08M | – | 5648 |
|
|
2021
Q1 | $1.08M | Buy |
+59,083
| New | +$1.08M | ﹤0.01% | 3851 |
|